In this study, we demonstrated that MOA inhibited growth and migration of prostate cancer PC3 cells in vitro and in vivo, and this effect resulted from inhibition of COX-2-mediated activation of the β-catenin signaling pathway. This evidence concerns the gene PTGS2 and prostate cancer.